Register for Upcoming Webinar on DEC. 8 @ 11AM
2025 China NMPA Bluebook is here:
The NMPA granted innovation approvals to Inari Medical’s FlowTriever Retrieval/ Aspiration System and issued a review report. The published review reports like this one serve as important references for you
In recent decades, the widespread application of dental implants in the field of dentistry has significantly improved the quality of life for countless edentulous patients. Below article, written by NMPA
The NMPA granted innovation approvals to Medtronic’s Extravascular Implantable Cardioverter Defibrillator (EV-ICD) and issued a review report. The published review reports like this one serve as important references for you
II. Regulatory Landscape and Global Market Integration NMPA The NMPA classifies punctal plugs as Class III medical devices under the code 16-07-05, denoting the highest level of regulatory scrutiny. Specialized
NMPA Regulations for AM Medical Devices NMPA places high importance on the regulation of 3D-printed medical devices. Custom AM implants typically fall under Class III high-risk devices and are subject
Additive Manufacturing (AM), or 3D printing technology, is triggering a profound technological revolution in the global orthopedic field. With its personalized, precise, and rapid manufacturing capabilities, 3D printing is now
Devices and Equipment for Cataract Treatment The success of cataract surgeries hinges on the use of advanced surgical equipment. The main technology driving cataract surgeries is the phacoemulsification system, which
Introduction China’s healthcare market, one of the largest and most rapidly growing in the world, presents numerous opportunities for foreign manufacturers, particularly in specialized fields such as ophthalmology. With a
China’s ophthalmology market is on the cusp of transformation, presenting lucrative opportunities for global device manufacturers. As one of the fastest-growing healthcare sectors in the country, ophthalmology is driven by
Case Study: Percutaneous Coronary Intervention (PCI) The centralized procurement reforms under the DRG/DIP framework have significantly impacted the costs associated with Percutaneous Coronary Intervention (PCI) procedures. While there have been
Under China’s regulatory framework for medical devices, innovative neurosurgical devices, due to their technical complexity and high application risks, must undergo stringent approval processes. This article, using three specific examples—neurosurgical
China’s NMPA issued a notice titled “Information Collection from Enterprises and Institutions Related to the Preparation of the Guideline for Intracranial Coils and Guideline for Stent Retrievers” on May 17,
Email: info@chinameddevice.com
Phone: 978-390-4453
USA Office:
1 Broadway, 14th Floor
Cambridge, MA 02142
CHINA Office:
Suite 1702C, Beijing Hailongshiyou Building, Chaoyang District, Beijing